TY - JOUR
T1 - Monitored Anesthesia Care Versus General Anesthesia
T2 - Experience With the Medtronic CoreValve
AU - Palermo, Christopher
AU - Degnan, Meredith
AU - Candiotti, Keith
AU - Salerno, Tomas
AU - de Marchena, Eduardo
AU - Rodriguez-Blanco, Yiliam
N1 - Publisher Copyright:
© 2016 Elsevier Inc.
PY - 2016/10/1
Y1 - 2016/10/1
N2 - Objective To compare monitored anesthesia care (MAC) and general anesthesia (GA) for transcatheter aortic valve implantation (TAVI). Design Retrospective, case-control study. Setting A large university-affiliated hospital system. Participants The study comprised patients who underwent TAVI with the Medtronic CoreValve (Medtronic, Minneapolis, MN) between 2011 and 2015. Interventions None. Measurements and Main Results MAC (n = 44) and GA (n = 21) were compared in 65 patients who underwent TAVI. Baseline characteristics/demographics, hospital stay, intraoperative conditions, and intensive care unit (ICU)/hospital stays were compared using the chi-square test, unpaired t-test, or binomial regression where appropriate. There were no significant differences between patient populations with regard to 30-day mortality, ICU/hospital stay, and complication rates. The GA group used more blood product. The rate of ICU readmission was greater in the GA group but did not reach statistical significance. Conclusions GA provides no significant advantages over MAC during TAVI.
AB - Objective To compare monitored anesthesia care (MAC) and general anesthesia (GA) for transcatheter aortic valve implantation (TAVI). Design Retrospective, case-control study. Setting A large university-affiliated hospital system. Participants The study comprised patients who underwent TAVI with the Medtronic CoreValve (Medtronic, Minneapolis, MN) between 2011 and 2015. Interventions None. Measurements and Main Results MAC (n = 44) and GA (n = 21) were compared in 65 patients who underwent TAVI. Baseline characteristics/demographics, hospital stay, intraoperative conditions, and intensive care unit (ICU)/hospital stays were compared using the chi-square test, unpaired t-test, or binomial regression where appropriate. There were no significant differences between patient populations with regard to 30-day mortality, ICU/hospital stay, and complication rates. The GA group used more blood product. The rate of ICU readmission was greater in the GA group but did not reach statistical significance. Conclusions GA provides no significant advantages over MAC during TAVI.
KW - CoreValve
KW - delirium
KW - propofol
KW - transcatheter aortic valve implantation (TAVI)
UR - http://www.scopus.com/inward/record.url?scp=84969509941&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84969509941&partnerID=8YFLogxK
U2 - 10.1053/j.jvca.2016.02.006
DO - 10.1053/j.jvca.2016.02.006
M3 - Article
C2 - 27222049
AN - SCOPUS:84969509941
SN - 1053-0770
VL - 30
SP - 1234
EP - 1237
JO - Journal of cardiothoracic and vascular anesthesia
JF - Journal of cardiothoracic and vascular anesthesia
IS - 5
ER -